Navigation Links
Epizyme, Inc. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on July 31, 2013
Date:7/24/2013

CAMBRIDGE, Mass., July 24, 2013 /PRNewswire/ -- Epizyme, Inc., (NASDAQ: EPZM) a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the Company will host a conference call and live audio webcast on Wednesday, July 31st, at 4:30 p.m. EDT to report its second quarter 2013 financial results and provide a corporate update.

In order to participate in the conference call, please dial 1-877-844-6886 (domestic) or 1-970-315-0315 (international) and refer to conference ID 17477005. The live webcast can be accessed under "Events and Presentations" in the Investor Relations section of the Company's website at www.epizyme.com.  

The archived webcast will be available on the Company's website beginning approximately two hours after the event.

About Epizyme, Inc.
Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment.

For more information, visit www.epizyme.com and connect with us on Twitter at @EpizymeRx.<
'/>"/>

SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epizyme, Inc. Announces Pricing of Initial Public Offering
2. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Henry Schein To Webcast Second Quarter 2013 Conference Call On Tuesday, August 6 At 10:00 a.m. ET
4. STAAR Surgical Announces Second Quarter 2013 Results Release Date And Conference Call And Webcast
5. Sangamo BioSciences Announces Second Quarter 2013 Conference Call And Webcast
6. UPDATE: Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2013 Results
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2013 Results
8. PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 26, 2013
9. HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
10. Volcano Corporation Presentation At Goldman Sachs Conference To Be Webcast
11. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Doctors from the Sheikh Zayed Institute for Pediatric ... are the first in the United ... but painful bone tumor that commonly occurs in children ... focused ultrasound (MR-HIFU) method. Two patients, 16-year-old Alfredo ... been treated successfully in a research study aimed at ...
(Date:5/27/2015)... Water Street Healthcare Partners , ... care industry, announced today that it has formed ... world,s leading global health care companies. The partnership expands ... established in 2013 as a new way to ... pharmaceutical products and medical devices. Water ...
(Date:5/27/2015)... , May 25, 2015 Research ... announced the addition of the "2015 Strategies ... to their offering. This comprehensive five-country ... designed to help current suppliers and potential market ... the European coagulation testing market during the next ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2European Coagulation Testing Market Strategies 2015 2
... 14, 2011 Reportlinker.com announces that a new ... Bone Metastases Therapeutics - Pipeline ... http://www.reportlinker.com/p0479826/Bone-Metastases-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html Bone Metastases ... 2017 Summary ...
... NEW YORK, April 14, 2011 Reportlinker.com ... is available in its catalogue: ... Generic Substitution Coupled With a Weak Pipeline ... http://www.reportlinker.com/p0481589/Sleep-Disorders-Market-to-2017---Generic-Substitution-Coupled-With-a-Weak-Pipeline-Will-Negatively-Impact-the-Market.html ...
Cached Medicine Technology:Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 9Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 2Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 3Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 4Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 5Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 6Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 7Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 8Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 9Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 10Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 11Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 12Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 13Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 14Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 15Reportlinker Adds Sleep Disorders Market to 2017 - Generic Substitution Coupled With a Weak Pipeline Will Negatively Impact the Market 16
(Date:5/27/2015)... (PRWEB) May 27, 2015 “ Nursing Homes ... care ,” reads the title of a recent April 2015 ... take elderly loved ones to the hospital, 20-plus years of ... This research shows that high-quality nursing homes are both safer ... With the quality of nursing homes varying widely, patients and ...
(Date:5/27/2015)... While hair transplantation has been used successfully ... study conducted by a physician member of the International ... follicle grafting can help treat patients with non-healing chronic ... ISHRS, which offers research grants for the purpose of ... In the past decade, numerous scientific studies have corroborated ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 CURE® ... (BCAN) , whose mission is to advance research, provide ... have joined forces to battle the fifth most common ... the bladder’s lining start to grow out of control. ... their families at every stage of the cancer experience ...
(Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2
... HealthDay Reporter , FRIDAY, April 27 (HealthDay News) -- Although ... to carry inhalers at school and 48 states have laws ... say that some kids are still being denied access ... school district handles this a little bit different, and for ...
... , FRIDAY, April 27 (HealthDay News) -- Given the ... shows that children prefer a living creature. Even babies ... animals, including those that may frighten many adults, such as ... Rutgers University found. The researchers conducted three separate experiments ...
... who are bullied are three times more likely than others to ... a new study. A team of researchers from the ... April 27 in the BMJ , could help identify those ... of self-harming behaviors included cutting and biting arms, pulling out clumps ...
... 26, 2012 - The mitotic spindle, an apparatus that ... than the standard textbook picture suggests, according to researchers ... (SEAS). The findings, which result from quantitative measurements ... journal Cell . The researchers used a ...
... Rochester Medical Center are testing whether different doses of an ... a standard dose in people with mild hypertension, possibly with ... launched clinical trial, funded with a $1.9 million grant from ... of its kind in the United States. The ...
... HealthDay Reporter , THURSDAY, April 26 (HealthDay News) -- ... help keep your brain functioning well as you age, new ... the highest intake of berries appeared to delay cognitive aging ... such as thinking, remembering and reasoning. "Given that ...
Cached Medicine News:Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 2Health News:Some Schools Don't Let Kids Carry Asthma Inhalers 3Health News:Bullied Children at Greater Risk for Self-Harm, Study Finds 2Health News:Slicing mitotic spindle with lasers, nanosurgeons unravel old pole-to-pole theory 2Health News:URMC clinical trial tests new regimen for hypertension 2Health News:Eating Berries Might Help Preserve Your Memory 2Health News:Eating Berries Might Help Preserve Your Memory 3
... macular health. Snellen charts available ... Easy to mount on most ... in a few minutes. Rapid ... Retinal vision testing without refraction ...
Eye Q Lite is ideal for color and red-free imaging used in general clinical and optometric casework such as anterior segmenting and diabetic screening....
The Genesis Camera meets the needs of those with specific requirements that cannot be met by a conventional 'chinrest' type camera....
The quick access to diabetic screening, panoramic images of the retina including peripheral area are available by using easy, semi automatic guidance of peripheral fixation....
Medicine Products: